Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock?

Company Overview - Hologic (HOLX) shares increased by 7.7% to $68.2 in the last trading session, following a period of 6.6% loss over the past four weeks, indicating a significant rebound in investor sentiment [1][2] - The rise in Hologic's stock price is attributed to renewed interest from private equity firms Blackstone and TPG in acquiring the company, which could lead to one of the largest healthcare take-private transactions of the year [2] Earnings Expectations - Hologic is expected to report quarterly earnings of $1.10 per share, reflecting an 8.9% year-over-year increase, with revenues projected at $1.03 billion, a 4.6% increase from the previous year [3] - Despite positive earnings and revenue growth expectations, the consensus EPS estimate for Hologic has been revised marginally lower over the last 30 days, which may indicate potential challenges for price appreciation [4] Industry Context - Hologic operates within the Zacks Medical - Instruments industry, where another company, Alcon (ALC), has seen a decline of 0.6% to $77.2, with a return of -13.9% over the past month [4] - Alcon's consensus EPS estimate has decreased by 3.8% to $0.77, representing a year-over-year change of -4.9%, and it also holds a Zacks Rank of 3 (Hold) [5]